Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer Gene Therapy market report explains the definition, types, applications, major countries, and major players of the Cancer Gene Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
OncoGenex Pharmaceuticals
Merck
Altor BioScience
Bluebird bio
Celgene
BioCancell
Shenzhen SiBiono GeneTech
GlaxoSmithKline
Amgen
Shanghai Sunway Biotech
Argenx
Transgene
SynerGene Therapeutics
Adaptimmune
By Type:
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
By End-User:
Hospitals
Diagnostics Centers
Research Institutes
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Cancer Gene Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Cancer Gene Therapy Outlook to 2028- Original Forecasts
-
2.2 Cancer Gene Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Cancer Gene Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Cancer Gene Therapy Market- Recent Developments
-
6.1 Cancer Gene Therapy Market News and Developments
-
6.2 Cancer Gene Therapy Market Deals Landscape
7 Cancer Gene Therapy Raw Materials and Cost Structure Analysis
-
7.1 Cancer Gene Therapy Key Raw Materials
-
7.2 Cancer Gene Therapy Price Trend of Key Raw Materials
-
7.3 Cancer Gene Therapy Key Suppliers of Raw Materials
-
7.4 Cancer Gene Therapy Market Concentration Rate of Raw Materials
-
7.5 Cancer Gene Therapy Cost Structure Analysis
-
7.5.1 Cancer Gene Therapy Raw Materials Analysis
-
7.5.2 Cancer Gene Therapy Labor Cost Analysis
-
7.5.3 Cancer Gene Therapy Manufacturing Expenses Analysis
8 Global Cancer Gene Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Cancer Gene Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Cancer Gene Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Cancer Gene Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Gene Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncolytic Virotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gene Transfer Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gene-Induced Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Gene Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Cancer Gene Therapy Market Analysis and Outlook till 2022
-
10.1 Global Cancer Gene Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Cancer Gene Therapy Consumption (2017-2022)
-
10.2.2 Canada Cancer Gene Therapy Consumption (2017-2022)
-
10.2.3 Mexico Cancer Gene Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Cancer Gene Therapy Consumption (2017-2022)
-
10.3.2 UK Cancer Gene Therapy Consumption (2017-2022)
-
10.3.3 Spain Cancer Gene Therapy Consumption (2017-2022)
-
10.3.4 Belgium Cancer Gene Therapy Consumption (2017-2022)
-
10.3.5 France Cancer Gene Therapy Consumption (2017-2022)
-
10.3.6 Italy Cancer Gene Therapy Consumption (2017-2022)
-
10.3.7 Denmark Cancer Gene Therapy Consumption (2017-2022)
-
10.3.8 Finland Cancer Gene Therapy Consumption (2017-2022)
-
10.3.9 Norway Cancer Gene Therapy Consumption (2017-2022)
-
10.3.10 Sweden Cancer Gene Therapy Consumption (2017-2022)
-
10.3.11 Poland Cancer Gene Therapy Consumption (2017-2022)
-
10.3.12 Russia Cancer Gene Therapy Consumption (2017-2022)
-
10.3.13 Turkey Cancer Gene Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Cancer Gene Therapy Consumption (2017-2022)
-
10.4.2 Japan Cancer Gene Therapy Consumption (2017-2022)
-
10.4.3 India Cancer Gene Therapy Consumption (2017-2022)
-
10.4.4 South Korea Cancer Gene Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Cancer Gene Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Cancer Gene Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Cancer Gene Therapy Consumption (2017-2022)
-
10.4.8 Thailand Cancer Gene Therapy Consumption (2017-2022)
-
10.4.9 Singapore Cancer Gene Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Cancer Gene Therapy Consumption (2017-2022)
-
10.4.11 Philippines Cancer Gene Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Cancer Gene Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Cancer Gene Therapy Consumption (2017-2022)
-
10.5.2 Colombia Cancer Gene Therapy Consumption (2017-2022)
-
10.5.3 Chile Cancer Gene Therapy Consumption (2017-2022)
-
10.5.4 Argentina Cancer Gene Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Cancer Gene Therapy Consumption (2017-2022)
-
10.5.6 Peru Cancer Gene Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Cancer Gene Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Cancer Gene Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Cancer Gene Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Cancer Gene Therapy Consumption (2017-2022)
-
10.6.3 Oman Cancer Gene Therapy Consumption (2017-2022)
-
10.6.4 Qatar Cancer Gene Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Cancer Gene Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Cancer Gene Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Cancer Gene Therapy Consumption (2017-2022)
-
10.7.2 South Africa Cancer Gene Therapy Consumption (2017-2022)
-
10.7.3 Egypt Cancer Gene Therapy Consumption (2017-2022)
-
10.7.4 Algeria Cancer Gene Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Cancer Gene Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Cancer Gene Therapy Consumption (2017-2022)
11 Global Cancer Gene Therapy Competitive Analysis
-
11.1 OncoGenex Pharmaceuticals
-
11.1.1 OncoGenex Pharmaceuticals Company Details
-
11.1.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Main Business and Markets Served
-
11.1.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Merck
-
11.2.1 Merck Company Details
-
11.2.2 Merck Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Merck Cancer Gene Therapy Main Business and Markets Served
-
11.2.4 Merck Cancer Gene Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Altor BioScience
-
11.3.1 Altor BioScience Company Details
-
11.3.2 Altor BioScience Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Altor BioScience Cancer Gene Therapy Main Business and Markets Served
-
11.3.4 Altor BioScience Cancer Gene Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bluebird bio
-
11.4.1 Bluebird bio Company Details
-
11.4.2 Bluebird bio Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bluebird bio Cancer Gene Therapy Main Business and Markets Served
-
11.4.4 Bluebird bio Cancer Gene Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Celgene
-
11.5.1 Celgene Company Details
-
11.5.2 Celgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Celgene Cancer Gene Therapy Main Business and Markets Served
-
11.5.4 Celgene Cancer Gene Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 BioCancell
-
11.6.1 BioCancell Company Details
-
11.6.2 BioCancell Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 BioCancell Cancer Gene Therapy Main Business and Markets Served
-
11.6.4 BioCancell Cancer Gene Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Shenzhen SiBiono GeneTech
-
11.7.1 Shenzhen SiBiono GeneTech Company Details
-
11.7.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Main Business and Markets Served
-
11.7.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GlaxoSmithKline
-
11.8.1 GlaxoSmithKline Company Details
-
11.8.2 GlaxoSmithKline Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GlaxoSmithKline Cancer Gene Therapy Main Business and Markets Served
-
11.8.4 GlaxoSmithKline Cancer Gene Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Amgen
-
11.9.1 Amgen Company Details
-
11.9.2 Amgen Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Amgen Cancer Gene Therapy Main Business and Markets Served
-
11.9.4 Amgen Cancer Gene Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Shanghai Sunway Biotech
-
11.10.1 Shanghai Sunway Biotech Company Details
-
11.10.2 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Shanghai Sunway Biotech Cancer Gene Therapy Main Business and Markets Served
-
11.10.4 Shanghai Sunway Biotech Cancer Gene Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Argenx
-
11.11.1 Argenx Company Details
-
11.11.2 Argenx Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Argenx Cancer Gene Therapy Main Business and Markets Served
-
11.11.4 Argenx Cancer Gene Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Transgene
-
11.12.1 Transgene Company Details
-
11.12.2 Transgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Transgene Cancer Gene Therapy Main Business and Markets Served
-
11.12.4 Transgene Cancer Gene Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 SynerGene Therapeutics
-
11.13.1 SynerGene Therapeutics Company Details
-
11.13.2 SynerGene Therapeutics Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 SynerGene Therapeutics Cancer Gene Therapy Main Business and Markets Served
-
11.13.4 SynerGene Therapeutics Cancer Gene Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Adaptimmune
-
11.14.1 Adaptimmune Company Details
-
11.14.2 Adaptimmune Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Adaptimmune Cancer Gene Therapy Main Business and Markets Served
-
11.14.4 Adaptimmune Cancer Gene Therapy Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Cancer Gene Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Cancer Gene Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oncolytic Virotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Gene Transfer Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Gene-Induced Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Cancer Gene Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Cancer Gene Therapy Market Analysis and Outlook to 2028
-
13.1 Global Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Cancer Gene Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Cancer Gene Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Cancer Gene Therapy
-
Figure of Cancer Gene Therapy Picture
-
Table Global Cancer Gene Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Cancer Gene Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oncolytic Virotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Transfer Consumption and Growth Rate (2017-2022)
-
Figure Global Gene-Induced Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Gene Therapy Consumption by Country (2017-2022)
-
Table North America Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure United States Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure Germany Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure China Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure Brazil Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Cancer Gene Therapy Consumption by Country (2017-2022)
-
Figure Australia Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Cancer Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table OncoGenex Pharmaceuticals Company Details
-
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Main Business and Markets Served
-
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Product Portfolio
-
Table Merck Company Details
-
Table Merck Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Gene Therapy Main Business and Markets Served
-
Table Merck Cancer Gene Therapy Product Portfolio
-
Table Altor BioScience Company Details
-
Table Altor BioScience Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor BioScience Cancer Gene Therapy Main Business and Markets Served
-
Table Altor BioScience Cancer Gene Therapy Product Portfolio
-
Table Bluebird bio Company Details
-
Table Bluebird bio Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird bio Cancer Gene Therapy Main Business and Markets Served
-
Table Bluebird bio Cancer Gene Therapy Product Portfolio
-
Table Celgene Company Details
-
Table Celgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Cancer Gene Therapy Main Business and Markets Served
-
Table Celgene Cancer Gene Therapy Product Portfolio
-
Table BioCancell Company Details
-
Table BioCancell Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCancell Cancer Gene Therapy Main Business and Markets Served
-
Table BioCancell Cancer Gene Therapy Product Portfolio
-
Table Shenzhen SiBiono GeneTech Company Details
-
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Main Business and Markets Served
-
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Cancer Gene Therapy Main Business and Markets Served
-
Table GlaxoSmithKline Cancer Gene Therapy Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Gene Therapy Main Business and Markets Served
-
Table Amgen Cancer Gene Therapy Product Portfolio
-
Table Shanghai Sunway Biotech Company Details
-
Table Shanghai Sunway Biotech Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Sunway Biotech Cancer Gene Therapy Main Business and Markets Served
-
Table Shanghai Sunway Biotech Cancer Gene Therapy Product Portfolio
-
Table Argenx Company Details
-
Table Argenx Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argenx Cancer Gene Therapy Main Business and Markets Served
-
Table Argenx Cancer Gene Therapy Product Portfolio
-
Table Transgene Company Details
-
Table Transgene Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transgene Cancer Gene Therapy Main Business and Markets Served
-
Table Transgene Cancer Gene Therapy Product Portfolio
-
Table SynerGene Therapeutics Company Details
-
Table SynerGene Therapeutics Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table SynerGene Therapeutics Cancer Gene Therapy Main Business and Markets Served
-
Table SynerGene Therapeutics Cancer Gene Therapy Product Portfolio
-
Table Adaptimmune Company Details
-
Table Adaptimmune Cancer Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adaptimmune Cancer Gene Therapy Main Business and Markets Served
-
Table Adaptimmune Cancer Gene Therapy Product Portfolio
-
Figure Global Oncolytic Virotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Transfer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene-Induced Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Cancer Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Cancer Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
